The company expects modest price rises at the next round of health-insurance-premium approvals, while the focus now is on the catching up of claims post the pandemic disruption. Macquarie suspects there is limited earnings risk to the upside in the short term as a result.

Nib Holdings also expects to agree on a new insurer for its Australasian travel product by Christmas. Macquarie retains a Neutral rating and $7.50 target.

Sector: Insurance.

Target price is $7.50.Current Price is $7.26. Difference: $0.24 - (brackets indicate current price is over target). If NHF meets the Macquarie target it will return approximately 3% (excluding dividends, fees and charges - negative figures indicate an expected loss).

© 2021 Acquisdata Pty Ltd., source FN Arena